Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell
DOI 10.1016/j.cell.2020.03.045

Cited by (1,009)

Items 101–200 of 1,009

  1. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
    Yinghui Liu, Gaowei Hu, Yuyan Wang, Wenlin Ren, Xiaomin Zhao, Fansen Ji, Yunkai Zhu, Fei Feng, Mingli Gong, Xiaohui Ju et al. · 2021 · Proceedings of the National Academy of Sciences
  2. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
    Shuo Du, Y. Cao, Qin-Yu Zhu, Pin Yu, Fei-Fei Qi, Guopeng Wang, Xiaoxia Du, L. Bao, Wei Deng, Hua Zhu et al. · 2020 · Cell
  3. SARS-CoV-2 spreads through cell-to-cell transmission
    Zeng, Cong, Evans, John P., King, Tiffany, Zheng, Yi-Min, Oltz, Eugene M., Whelan, Sean P. J., Saif, Linda J., Peeples, Mark E., Liu, Shan-Lu · 2022 · Proceedings of the National Academy of Sciences
  4. The Immune Nature of Platelets Revisited
    Amal Maouia, Johan Rebetz, Rick Kapur, John W. Semple · 2020 · Transfusion Medicine Reviews
  5. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis
    Mario Rotondi, Francesca Coperchini, G. Ricci, Marco Denegri, Laura Croce, Samuel Tata Ngnitejeu, Laura Villani, Flavia Magri, Francesco Latrofa, L. Chiovato · 2020 · Journal of Endocrinological Investigation
  6. Humoral Responses and Serological Assays in SARS-CoV-2 Infections
    Yannick Galipeau, M. Greig, George Liu, M. Driedger, Marc-André Langlois · 2020 · Frontiers in Immunology
  7. Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane
    Hyeonuk Woo, Sang‐Jun Park, Yeol Kyo Choi, Taeyong Park, Maham Tanveer, Yiwei Cao, Nathan R. Kern, Jumin Lee, Min Sun Yeom, Tristan Ian Croll et al. · 2020 · The Journal of Physical Chemistry B
  8. Structure of SARS-CoV-2 spike protein
    Jun Zhang, Tianshu Xiao, Yongfei Cai, Bing Chen · 2021 · Current Opinion in Virology
  9. Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
    Amanat Ali, Ranjit Vijayan · 2020 · Scientific Reports
  10. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
    Yin-Feng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiang-Ping Li, Pingping Zhou, Xin-Chun Chen, Zhe Liu, Xiao Zhang et al. · 2021 · ACS Nano
  11. Comparison of nonhuman primates identified the suitable model for COVID-19
    Shuaiyao Lu, Yuan Zhao, Wenhai Yu, Yun Yang, Jiahong Gao, Junbin Wang, Dexuan Kuang, Mengli Yang, Jing Yang, Chunxia Ma et al. · 2020 · Signal Transduction and Targeted Therapy
  12. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
    Yongfei Cai, Jun Zhang, Tianshu Xiao, Christy L. Lavine, Shaun Rawson, Hanqin Peng, Haisun Zhu, Krishna Anand, Pei Tong, Avneesh Kumar Gautam et al. · 2021 · Science
  13. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
    Alsoussi, Wafaa B, Turner, Jackson S, Case, James B, Zhao, Haiyan, Schmitz, Aaron J, Zhou, Julian Q, Chen, Rita E, Lei, Tingting, Rizk, Amena A, McIntire, Katherine M et al. · 2020 · The Journal of Immunology
  14. Immunological imprinting of the antibody response in COVID-19 patients
    Aydillo, Teresa, Rombauts, Alexander, Stadlbauer, Daniel, Aslam, Sadaf, Abelenda-Alonso, Gabriela, Escalera, Alba, Amanat, Fatima, Jiang, Kaijun, Krammer, Florian, Carratala, Jordi et al. · 2021 · Nature Communications
  15. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
    Cecylia S. Lupala, Yongjin Ye, Hong Chen, Xiao‐Dong Su, Haiguang Liu · 2021 · Biochemical and Biophysical Research Communications
  16. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
    Ariane Sternberg, Cord Naujokat · 2020 · Life Sciences
  17. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
    M. Eugenia Dieterle, Denise Haslwanter, Robert H. Bortz, Ariel S. Wirchnianski, Gorka Lasso, Olivia Vergnolle, Shawn A. Abbasi, J. Maximilian Fels, Ethan Laudermilch, Catalina Florez et al. · 2020 · Cell Host & Microbe
  18. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset
    Patrícia Figueiredo‐Campos, Birte Blankenhaus, Catarina Mota, Andréia Gomes, Marta Serrano, Silvia Ariotti, Catarina Januária Mendes da Costa, Helena Nunes‐Cabaço, António M. Mendes, Pedro Gaspar et al. · 2020 · European Journal of Immunology
  19. The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
    Carina Conceicao, Nazia Thakur, Stacey Human, James T. Kelly, Leanne Logan, Dagmara Bialy, Sushant Bhat, Phoebe Stevenson-Leggett, Adrian K. Zagrajek, Philippa Hollinghurst et al. · 2020 · PLoS Biology
  20. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
    Emanuele Andreano, E. Nicastri, Ida Paciello, P. Pileri, Noemi Manganaro, G. Piccini, A. Manenti, Elisa Pantano, A. Kabanova, M. Troisi et al. · 2021 · Cell
  21. De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
    Linsky, Thomas W., Vergara, Renan, Codina, Nuria, Nelson, Jorgen W., Walker, Matthew J., Su, Wen, Barnes, Christopher O., Hsiang, Tien-Ying, Esser-Nobis, Katharina, Yu, Kevin et al. · 2020 · Science
  22. Nanoparticle-Based Strategies to Combat COVID-19
    Riddhiman Medhi, Pannaree Srinoi, Nhat M. Ngo, Hung-Vu Tran, T. Randall Lee · 2020 · ACS Applied Nano Materials
  23. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
    Xiaoyi Fan, Duanfang Cao, Lingfei Kong, Xinzheng Zhang · 2020 · Nature Communications
  24. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
    Qi Yang, Thomas A. Hughes, Anju Kelkar, Xinheng Yu, Kai Cheng, Sheldon Park, Wei‐Chiao Huang, Jonathan F. Lovell, Sriram Neelamegham · 2020 · eLife
  25. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
    Maolin Lu, Pradeep Devappa Uchil, Wenwei Li, Desheng Zheng, Daniel S. Terry, Jason Gorman, Wei Shi, Baoshan Zhang, Tongqing Zhou, Shilei Ding et al. · 2020 · Cell Host & Microbe
  26. Molecular basis of receptor binding and antibody neutralization of Omicron
    Hong Qin, Wenyu Han, Jiawei Li, Shiqi Xu, Yifan Wang, Cong Xu, Zuyang Li, Yanxing Wang, Chao Zhang, Zhong Wei Huang et al. · 2022 · Nature
  27. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
    Giuseppina Mariano, Rebecca J. Farthing, Shamar L. M. Lale-Farjat, Julien R. C. Bergeron · 2020 · Frontiers in Molecular Biosciences
  28. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
    Jarrod Shilts, Thomas W. M. Crozier, Edward J. D. Greenwood, Paul J. Lehner, Gavin James Wright · 2021 · Scientific Reports
  29. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
    Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, Raghunath Chatterjee · 2020 · Infection Genetics and Evolution
  30. COVID-19 and SARS-CoV-2. Modeling the present, looking at the future
    Ernesto Estrada · 2020 · Physics Reports
  31. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells
    Carpinteiro, Alexander, Edwards, Michael J., Hoffmann, Markus, Kochs, Georg, Gripp, Barbara, Weigang, Sebastian, Adams, Constantin, Carpinteiro, Elisa, Gulbins, Anne, Keitsch, Simone et al. · 2020 · Cell Reports Medicine
  32. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
    Ma’mon M. Hatmal, Walhan Alshaer, Mohammad A. I. Al-Hatamleh, Malik Hatmal, Othman Smadi, Mutasem O. Taha, Ayman J. Oweida, Jennifer C. Boer, Rohimah Mohamud, Magdalena Plebanski · 2020 · Cells
  33. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution
    Hongye Wang, Xian Wu, Xiaomei Zhang, Xin Hou, Te Liang, Dan Wang, Fei Teng, Jiayu Dai, Hu Duan, Shubin Guo et al. · 2020 · ACS Central Science
  34. One year update on the COVID-19 pandemic: Where are we now?
    Sanjay Kumar Mishra, Timir Tripathi · 2020 · Acta Tropica
  35. The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
    Lauren A. Callender, Michelle Curran, Stephanie M. Bates, Maelle Mairesse, Julia Weigandt, Catherine Jean Betts · 2020 · Frontiers in Immunology
  36. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)
    Jong-Hwan Lee, Minsuk Choi, Yujin Jung, Sung Kyun Lee, Chang‐Seop Lee, Jung Kim, Jong-Woo Kim, Nam Hoon Kim, Bum‐Tae Kim, Hong Gi Kim · 2020 · Biosensors and Bioelectronics
  37. Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
    Irene Ramos, Konstantinos Stamatakis, Clara L. Oeste, Dolores Pérez‐Sala · 2020 · International Journal of Molecular Sciences
  38. Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology
    Kieran Dee, Daniel Max Goldfarb, Joanne Haney, Julien A R Amat, Vanessa Herder, Meredith E. Stewart, Agnieszka M. Szemiel, Marc Baguelin, Pablo R. Murcia · 2021 · The Journal of Infectious Diseases
  39. Furin: A Potential Therapeutic Target for COVID-19
    Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, Mingxue Li, Yang Liu, Qingzhe Zhang, Peng Zhang, Yali Wang et al. · 2020 · iScience
  40. Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection
    Li Guo, Zhiqian Yao, Lu Yang, Hao Zhang, Yu Qi, Lu Gou, Xi Wang, Dingxin Liu, Lei Zhang, Yilong Cheng et al. · 2020 · Chemical Engineering Journal
  41. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
    Walls, Alexandra C., Miranda, Marcos C., Schäfer, Alexandra, Pham, Minh N., Greaney, Allison, Arunachalam, Prabhu S., Navarro, Mary-Jane, Tortorici, M. Alejandra, Rogers, Kenneth, O’Connor, Megan A. et al. · 2021 · Cell
  42. COVID-19 and Obesity: Dangerous Liaisons
    Grazia Caci, Adriana Albini, Mario Malerba, Douglas McClain Noonan, Patrizia Pochetti, Riccardo Polosa · 2020 · Journal of Clinical Medicine
  43. Peptide and peptide-based inhibitors of SARS-CoV-2 entry
    Desirée Schütz, Yasser B. Ruiz‐Blanco, Jan Münch, Frank Kirchhoff, Elsa Sánchez‐García, Janis A. Müller · 2020 · Advanced Drug Delivery Reviews
  44. Comparative ACE2 variation and primate COVID-19 risk
    Amanda Dawn Melin, Mareike C. Janiak, Frank Marrone, Paramjit S. Arora, James P. Higham · 2020 · Communications Biology
  45. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
    Bin Wang, Lei Zhang, Yongqiang Wang, Tong Dai, Ziran Qin, Fangfang Zhou, Long Zhang · 2022 · Signal Transduction and Targeted Therapy
  46. A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective
    Mitko Madjunkov, Michal Dviri, Clifford Lawrence Librach · 2020 · Journal of Ovarian Research
  47. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
    Ku, Zhiqiang, Xie, Xuping, Davidson, Edgar, Ye, Xiaohua, Su, Hang, Menachery, Vineet D., Li, Yize, Yuan, Zihao, Zhang, Xianwen, Muruato, Antonio E. et al. · 2021 · Nature Communications
  48. Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
    Lili Wu, Qian Chen, Kefang Liu, Jia Wang, Pengcheng Han, Yanfang Zhang, Yu Hu, Yumin Meng, Xiaoqian Pan, Chengpeng Qiao et al. · 2020 · Cell Discovery
  49. Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
    Ruodan Xu, Mingfei Shi, Jing Li, Ping Song, Ning Li · 2020 · Frontiers in Bioengineering and Biotechnology
  50. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor
    Anne M. Davidson, Jan A Wysocki, DANIEL C. BATLLE · 2020 · Hypertension
  51. Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
    Yifan Wang, Caixuan Liu, Chao Zhang, Yanxing Wang, Hong Qin, Shiqi Xu, Zuyang Li, Yong Ping Yang, Zhong Wei Huang, Yao Cong · 2022 · Nature Communications
  52. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
    Hirofumi Ohashi, Koichi Watashi, Wakana Saso, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim et al. · 2021 · iScience
  53. Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress
    Luiza Mendonça, Andrew Howe, James Boris Gilchrist, Yuewen Sheng, Dapeng Sun, Michael L. Knight, Laura C. Zanetti-Domingues, Benji C. Bateman, Anna-Sophia Krebs, Long Chen et al. · 2021 · Nature Communications
  54. Human SARS CoV ‐2 spike protein mutations
    Lalitha Guruprasad · 2021 · Proteins Structure Function and Bioinformatics
  55. Impact of Thiol–Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
    Sanchita Hati, Sudeep Bhattacharyya · 2020 · ACS Omega
  56. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation
    Matthew McCallum, Alexandra C. Walls, John E. Bowen, Davide Corti, David Veesler · 2020 · Nature Structural & Molecular Biology
  57. ACE2-independent infection of T lymphocytes by SARS-CoV-2
    Xu-Rui Shen, Rong Geng, Qian Li, Ying Chen, Shufen Li, Qi Ming Wang, Juan Min, Yong Ping Yang, Bei Li, Ren-Di Jiang et al. · 2022 · Signal Transduction and Targeted Therapy
  58. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
    Gopal S. Gupta · 2022 · Inflammation
  59. Plasma-Activated Water: Physicochemical Properties, Generation Techniques, and Applications
    Kiing S. Wong, Nicholas S. L. Chew, Mary Low, Ming K. Tan · 2023 · Processes
  60. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
    Nicholas K. Hurlburt, Emilie Seydoux, Yu-Hsin Wan, Venkata Viswanadh Edara, Andrew B. Stuart, Junli Feng, Mehul S. Suthar, Andrew T. McGuire, Leonidas Stamatatos, Marie Pancera · 2020 · Nature Communications
  61. A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
    Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, Roya Ghanavati, Moloudsadat Motahar, Mohammad Sholeh, Hossein Ghahramanpour, Saeed Khoshnood · 2022 · Frontiers in Microbiology
  62. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts
    Xiaofeng Zhai, Jiumeng Sun, Ziqing Yan, Jie Zhang, Jin Zhao, Zongzheng Zhao, Qi Gao, Wan-Ting He, Michael Veit, Shuo Su · 2020 · Journal of Virology
  63. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity
    Junxian Ou, Zhonghua Zhou, Ruixue Dai, Jing Zhang, Shan Zhao, Xiaowei Wu, Wendong Lan, Yi Ren, Lilian Cui, Qiaoshuai Lan et al. · 2021 · Journal of Virology
  64. Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
    Milena Sokołowska, Zuzanna Małgorzata Łukasik, Ioana Octavia Agache, Cezmi A. Akdiş, Deniz Akdiş, Mübeccel Akdiş, Weronika Barcik, Helen Annaruth Brough, Thomas Eiwegger, Andrzej Eljaszewicz et al. · 2020 · Allergy
  65. Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
    Pengcheng Han, Chao Su, Yanfang Zhang, Chongzhi Bai, Anqi Zheng, Chengpeng Qiao, Qing Wang, Sheng Niu, Qian Chen, Yuqin Zhang et al. · 2021 · Nature Communications
  66. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
    David L. Sulzer, Angelo Antonini, Valentina Leta, Anna Starikovsky Nordvig, Richard Jay Smeyne, James E. Goldman, Osama Al‐Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco et al. · 2020 · npj Parkinson s Disease
  67. Exploration of nanozymes in viral diagnosis and therapy
    Jiyoung Lee, Hongwei Liao, Qiyue Wang, Jieun Han, Jun‐Hyeok Han, Ha Eun Shin, Minghua Ge, Wooram Park, Fangyuan Li · 2022 · Exploration
  68. Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
    Linjie Li, Hanyi Liao, Yumin Meng, Weiwei Li, Pengcheng Han, Kefang Liu, Qing Wang, Dedong Li, Yanfang Zhang, Liang Wang et al. · 2022 · Cell
  69. The Science of Frailty
    Caroline Park, Fred Ko · 2021 · Clinics in Geriatric Medicine
  70. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
    Erin F. Balcom, Avindra Nath, Christopher Power · 2021 · Brain
  71. Cell entry by SARS-CoV-2
    Ruchao Peng, Lian-Ao Wu, Qingling Wang, Jianxun Qi, George F. Gao · 2021 · Trends in Biochemical Sciences
  72. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia
    Aubin Moutal, Laurent Martin, Lisa Boinon, Kimberly Gómez, Dongzhi Ran, Yuan Zhou, Harrison J. Stratton, Song Cai, Shizhen Luo, Kerry Beth Gonzalez et al. · 2020 · Pain
  73. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
    Aneesha Achar, Chaitali Ghosh · 2020 · Cells
  74. Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
    Shan, Sisi, Luo, Shitong, Yang, Ziqing, Hong, Junxian, Su, Yufeng, Ding, Fan, Fu, Lili, Li, Chenyu, Chen, Peng, Ma, Jianzhu et al. · 2022 · Proceedings of the National Academy of Sciences
  75. The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor
    Esther S. Brielle, Dina Schneidman‐Duhovny, Michal Linial B · 2020 · Viruses
  76. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
    Zhennan Zhao, Jingya Zhou, Mingxiong Tian, Min Huang, Sheng Liu, Yufeng Xie, Pu Han, Chongzhi Bai, Pengcheng Han, Anqi Zheng et al. · 2022 · Nature Communications
  77. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
    Jim Baggen, Maarten Jacquemyn, Leentje Persoons, Els Vanstreels, Valerie E. Pye, Antoni G. Wrobel, Valeria Calvaresi, Stephen R. Martin, Chloë Roustan, Nora Cronin et al. · 2023 · Cell
  78. Pathogenesis of Respiratory Viral and Fungal Coinfections
    Fabián Salazar, Elaine Bignell, Gordon D. Brown, Peter C. Cook, Adilia Warris · 2021 · Clinical Microbiology Reviews
  79. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
    Tahir S. Pillay · 2020 · Journal of Clinical Pathology
  80. Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation
    Bahaa Jawad, Puja Adhikari, Rudolf Podgornik, W. Y. Ching · 2021 · Journal of Chemical Information and Modeling
  81. Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines
    Zhiwei Li, Zhiqian Ma, Yang Li, Sheng Gao, Shuqi Xiao · 2020 · Microbial Pathogenesis
  82. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
    Kun Xu, Ping Gao, Sheng Liu, Shuaiyao Lu, Wenwen Lei, Tianyi Zheng, Xueyuan Liu, Yufeng Xie, Zhennan Zhao, Shuxin Guo et al. · 2022 · Cell
  83. Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
    J. Ge, Ruoke Wang, B. Ju, Qi Zhang, Jing Sun, Peng Chen, Senyan Zhang, Yuling Tian, S. Shan, Lin Cheng et al. · 2021 · Nature Communications
  84. The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
    Shawn M. Costello, Sophie R. Shoemaker, Helen T. Hobbs, Annalee W. Nguyen, Ching‐Lin Hsieh, Jennifer A. Maynard, Jason S. McLellan, John E. Pak, Susan Marqusee · 2022 · Nature Structural & Molecular Biology
  85. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2
    Balaji Gowrivel Vijayakumar, Deepthi Ramesh, Annu Joji, Jayadharini Jayachandra prakasan, Tharanikkarasu Kannan · 2020 · European Journal of Pharmacology
  86. Antiviral Polymers: Past Approaches and Future Possibilities
    Rachel H. Bianculli, Jonathan D. Mase, Michael D. Schulz · 2020 · Macromolecules
  87. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
    Subodh Kumar Samrat, Anil Mathew Tharappel, Zhong Li, Hongmin Li · 2020 · Virus Research
  88. Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
    Tânia F. Custódio, Hrishikesh Das, Daniel J. Sheward, Leo Hanke, Samuel Pažický, Joanna Pieprzyk, Michèle Sorgenfrei, Martin A. Schroer, Andrey Yu. Gruzinov, Cy Michael Jeffries et al. · 2020 · Nature Communications
  89. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
    S. Long, R. Olsen, Paul A. Christensen, David W. Bernard, James J. Davis, M. Shukla, M. Nguyen, M. Saavedra, Prasanti Yerramilli, Layne Pruitt et al. · 2020 · mBio
  90. Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
    Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, Pejman Mokhtari, Maryam Nemati · 2020 · Scandinavian Journal of Immunology
  91. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
    Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, Benazir Ashiana Ali, Anthony Zulli, Vasso Apostolopoulos · 2021 · International Journal of Molecular Sciences
  92. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
    Hua Qin, Andong Zhao · 2020 · Protein & Cell
  93. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)
    Fangfang Huang, Ying Li, Elaine Lai‐Han Leung, Xiaohua Liu, Kaifeng Liu, Wang Qu, Yongqi Lan, Xiaoling Li, Haibing Yu, Liao Cui et al. · 2020 · Pharmacological Research
  94. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection
    François Trottein, Harry Sokol · 2020 · Cell Reports
  95. A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
    Carmen Riggioni, Pasquale Comberiati, Mattia Giovannini, Ioana Octavia Agache, Mübeccel Akdiş, Magna Alves‐Correia, Josep M. Antó, Alessandra Arcolacı, Ahmet Kürşat Azkur, Dilek Azkur et al. · 2020 · Allergy
  96. Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
    Young‐Jun Park, Anna De Marco, Tyler N. Starr, Zhuoming Liu, Dora Pinto, Alexandra C. Walls, Fabrizia Zatta, Samantha K. Zepeda, John E. Bowen, Kaitlin R. Sprouse et al. · 2022 · Science
  97. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
    Letícia Adrielle dos Santos, Pedro Germano de Góis Filho, Ana Maria Fantini Silva, João Victor Gomes dos Santos, Douglas Siqueira Santos, Marília Marques Aquino, Rafaela Mota de Jesus, Maria Luíza Dória Almeida, João S. Silva, Daniel Martin Altmann et al. · 2021 · Journal of Infection
  98. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
    Kefang Liu, Xiaoqian Pan, Linjie Li, Feng Yu, Anqi Zheng, Pei Du, Pengcheng Han, Yumin Meng, Yanfang Zhang, Lili Wu et al. · 2021 · Cell
  99. SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response
    Syed Nabeel‐Shah, Hyunmin Lee, Nujhat Ahmed, Giovanni L. Burke, Shaghayegh Farhangmehr, Kanwal Ashraf, Shuye Pu, Ulrich Braunschweig, Guoqing Zhong, Hong Wei et al. · 2021 · iScience
  100. Asthma-associated risk for COVID-19 development
    Chrysanthi L. Skevaki, Карсонова Антонина Васильевна, Alexander Viktorovich Karaulov, Min Xie, Harald E. Renz · 2020 · Journal of Allergy and Clinical Immunology